July 22, 2011 | Filed under: Health,News | Posted by:
The FDA warns patients taking the atrial fibrillation drug Multaq (dronedarone) to call their doctors. Multaq doubled deaths and strokes in a study of patients with permanent atrial fibrillation.
Posted by
on July 22, 2011. Filed under Health, News.
You can follow any responses to this entry through the RSS 2.0.
You can skip to the end and leave a response. Pinging is currently not allowed.
Posted by
on July 22, 2011. Filed under